Rick Monsma

Dr. Monsma oversees all NYSCF Research Institute laboratory operations, including day to day functioning, project planning, and strategic development. Rick started his career as a Post-doc at the NIH and thereafter moved to an industry position with Hoffman-LaRoche in Basel, Switzerland where he focused on the identification and characterization of G-protein Coupled Receptors. From Roche Rick was recruited to Schering-Plough to set up and lead a group devoted to identifying ligands for orphan GPCRs. Later, he lead the High Throughput Screening (HTS) group at Schering-Plough, including development of capabilities to address screening of several million compounds in 1536 well format. Following the Merck/Schering merger, Rick transitioned to leading a Cell Pharmacology group, which developed and conducted diverse cell based assays in support of Drug Discovery projects in Neuroscience, Diabetes and Cardiovascular Diseases.